Deferred stent implantation in patients with ST segment elevation myocardial infarction with high thrombus burden

Main Article Content

Mohamed Abdel-shafy Tabl*
Khaled Emad El-Rabbat
Eman Said El-keshk
Gamal Mohamed Gharib

Abstract

Recent guidelines recommend against deferred stenting as a routine strategy in STEMI patients.


Objectives: current study aimed to assess whether deferred stenting strategy in primary PCI might reduce angiographic or in-hospital major adverse cardiac events in comparison to immediate stenting.


Methods: one hundred patients of STEMI with high thrombus burden divided equally into; 50 patients (group 1) treated with immediate stenting and 50 patients (group 2) treated with deferred stenting. Procedural angiographic events were the primary endpoints, while in hospital MACE were designed as secondary endpoints.


Results: patients of deferred stenting group had statistically significant reduction of distal embolization, slow flow and no reflow (P value = 0.016). In contrast, deferred strategy didn’t improve the short term clinical outcomes. Composite of MACEs was statistically significant in the deferred stenting group (20%) versus only (6%) in the immediate stenting group (P value = 0.037).


Conclusion: Deferred stenting in patients with STEMI those with high thrombotic burden improves only the angiographic outcomes but could not improve the short term clinical outcomes in comparison to immediate stenting. Deferred stenting shouldn’t be used as a routine strategy in STEMI patients.

Downloads

Download data is not yet available.

Article Details

Tabl, M. A.- shafy, El-Rabbat, K. E., El-keshk, E. S., & Gharib, G. M. (2019). Deferred stent implantation in patients with ST segment elevation myocardial infarction with high thrombus burden. Journal of Cardiovascular Medicine and Cardiology, 6(1), 001–005. https://doi.org/10.17352/2455-2976.000080
Research Articles

Copyright (c) 2019 Tabl MA, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.

We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.

Peertechz accomplice with- [CC BY 4.0]

Explanation

'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.

Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.

With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:

License Name

Permission to read and download

Permission to display in a repository

Permission to translate

Commercial uses of manuscript

CC BY 4.0

Yes

Yes

Yes

Yes

The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.

Ndrepepa G, Tiroch K, Fusaro M (2010) 5-year prognostic value of no-reflow phenomenon after percutane­ous coronary intervention in patients with acute myocardial infarc­tion. J Am Coll Cardiol 55: 83-89. Link: https://goo.gl/MWzKwq

Meneveau N, Seronde M, Descotes-Genon V, Dutheil J, Chopard R, et al. (2009) Immediate versus delayed angioplasty in infarct-related arteries with TIMI III flow and ST segment recovery: a matched comparison in acute myocardial infarction patients. Clin Res Cardiol 98: 257-264. Link: https://goo.gl/4ni15n

Kim J, Choi D, Jang Y, Lee CJ, Lee SH, et al. (2010) Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial. JACC Cardiovasc Interv 3: 332-339. Link: https://goo.gl/bfkDYX

Di Pasquale P, Cannizzaro S, Parrinello G, Giambanco F, Vitale G, et al. (2006) Is delayed percutaneous coronary intervention better than immediate in reperfused myocardial infarction? Six months follow up findings. J Thromb Thrombolysis 21: 147-157. Link: https://goo.gl/J2C4vo

Belle L, Motreff P, Mangin L, Rangé G, Marcaggi X, et al. (2016) Comparison of immediate with delayed stenting using the Minimalist Immediate Mechanical Intervention approach in acute ST-segment-elevation myocardial infarction: The MIMI study. Circ Cardiovasc Interv 9: e003388. Link: https://goo.gl/R13por

Gibson CM, Lemos JA, Murphy SA, Marble SJ, McCabe CH, et al. (2001) Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy. Circulation 103: 2550-2554. Link: https://goo.gl/2TM9xp

Massimo F, Arnow H, Christian A, Albus C, Brotons C, et al. (2016) European Guidelines on cardiovascular disease prevention in clinical practice European Heart Journal 37: 2315-2381. Link: https://goo.gl/7Ea7ek

Nicoli G, Spaziani C, Marino M, Pontecorvo ML, Cosentin N, et al. (2010) Effect of chronic aspirin therapy on angiographic thrombotic burden in patients admitted for a first ST-elevation myocardial infarction. Am J Cardiol 105: 587-591. Link: https://goo.gl/FFsY3Q

Andreson J, Adams C, Antman E, Bridges CR, Califf RM, et al. (2007) ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am CollCardiol 50: e1-e157. Link: https://goo.gl/6udgYw

Iwakura K, Ito H, Kawano S, Okamura A, Kurotobi T, et al. (2006) Chronic pre-treatment of statins is associated with the reduction of the no-reflow phenomenon in the patients with reperfused acute myocardial infarction. Eur Heart J 27: 534-539. Link: https://goo.gl/pRja52

Franz-Josef N, Miguel Sousa-U, Anders A (2018) ESC/EACTS Guidelines on myocardial revascularization, European Heart Journal 1-96. Link: https://goo.gl/1JzTTr

Henriques J, Zijlstra F, Ottervanger S, de Boer MJ, van t Hof AW, et al. (2002) Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur Heart J 23: 1112-1117. Link: https://goo.gl/mnLoLm

De Luca G, Suryapranata H, Stone G, Antoniucci D, Tcheng JE, et al. (2005) Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. JAMA 293: 1759-1765. Link: https://goo.gl/M4zwwd

Belle L, Motreff P, Mangin L, Rangé G2, Marcaggi X, et al. (2016) Comparison of immediate with delayed stenting using the Minimalist Immediate Mechanical Intervention approach in acute ST-segment-elevation myocardial infarction: The MIMI study. Circ Cardiovasc Interv 9: e003388. Link: https://goo.gl/yohkUh

Tang L, Zhou S, Hu X, Fang ZF, Shen XQ (2011) Effect of delayed vs immediate stent implantation on myocardial perfusion and cardiac function in patients with ST-segment elevation myocar­dial infarction undergoing primary percutaneous intervention with thrombus aspiration. Can J Cardiol 27: 541-547. Link: https://goo.gl/BaeeVY

Cafri C, Svirsky R, Zelingher J, Slutky O, Kobal S, et al. (2004) Improved procedural results in cor­onary thrombosis are obtained with delayed percutaneous coronary interventions. J Invasive Cardiol 16: 69-71. Link: https://goo.gl/7r8i99

Meneveau N, Seronde M, Descotes-Genon V, Dutheil J, Chopard R, et al. (2009) Immediate versus delayed angioplasty in infarct-related arteries with TIMI III flow and ST segment recovery: a matched comparison in acute myocardial infarction patients. Clin Res Cardiol 98: 257-264. Link: https://goo.gl/SW1446

Kelbaek H, Hofsten DE, Kober L (2016) Deferred versus conventional stent implantation in patients with ST-segment elevation myocardial infarction (DANAMI 3-DEFER): An open-label, randomised controlled trial. Lancet 387: 2199–2206. Link: https://goo.gl/GG5uak

Tang L, Zhou S, Hu X, Fang ZF, Shen XQ (2011) Effect of delayed vs immediate stent implantation on myocardial perfusion and cardiac function in patients with ST-segment elevation myocar­dial infarction undergoing primary percutaneous intervention with thrombus aspiration. Can J Cardiol 27: 541-547. Link: https://goo.gl/XAyt3p